UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 279

Sortiert nach

Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia

British journal of haematology, 2020-06, Vol.189 (5), p.815-825

2020

Volltextzugriff (PDF)

NF-kB and the CLL microenvironment

Frontiers in oncology, 2023-03, Vol.13, p.1169397-1169397

2023

Volltextzugriff (PDF)

Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial)

PloS one, 2019-04, Vol.14 (4), p.e0212903-e0212903

2019

Volltextzugriff (PDF)

Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells

Haematologica (Roma), 2013-12, Vol.98 (12), p.1930-1938

2013

Volltextzugriff (PDF)

Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.105-11, Article 105

2024

Volltextzugriff (PDF)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma

Frontiers in oncology, 2023-06, Vol.13, p.1181660-1181660

2023

Volltextzugriff (PDF)

Targeting CDK9 for treatment of colorectal cancer

Molecular oncology, 2019-10, Vol.13 (10), p.2178-2193

2019

Volltextzugriff (PDF)

Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling

Cancers, 2023-09, Vol.15 (19), p.4736

2023

Volltextzugriff (PDF)

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma

Cancers, 2022-03, Vol.14 (6), p.1489

2022

Volltextzugriff (PDF)

Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia

Cancers, 2022-03, Vol.14 (7), p.1600

2022

Volltextzugriff (PDF)

The role of Bcl-2 family proteins in chronic lymphocytic leukaemia

Leukemia research, 2010-07, Vol.34 (7), p.837-842

2010

Volltextzugriff (PDF)

Developing a post-myocardial infarction medicines optimisation clinic: core competencies for upskilling pharmacists and initial patient feedback

BMJ open quality, 2023-04, Vol.12 (2), p.e002152

2023

Volltextzugriff (PDF)

The HSP90 inhibitor NVP‐AUY922‐AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells

British journal of haematology, 2013-04, Vol.161 (1), p.57-67

2013

Volltextzugriff (PDF)

Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

Haematologica (Roma), 2008-05, Vol.93 (5), p.662-669

2008

Volltextzugriff (PDF)

Computational modeling of DLBCL predicts response to BH3-mimetics

NPJ systems biology and applications, 2023-06, Vol.9 (1), p.23-23, Article 23

2023

Volltextzugriff (PDF)

Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2009-02, Vol.27 (5), p.763-769

2009

Volltextzugriff (PDF)

Is venetoclax a new wonder drug in CLL?

British journal of haematology, 2019-05, Vol.185 (4), p.643-646

2019

Volltextzugriff (PDF)

UK Expert Consensus Statement for the Optimal Use and Clinical Utility of Leadless Pacing Systems on Behalf of the British Heart Rhythm Society

Arrhythmia & electrophysiology review, 2022-04, Vol.11, p.e19-e19

2022

Volltextzugriff (PDF)

A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL

Oncotarget, 2015-10, Vol.6 (32), p.32669-32680

2015

Volltextzugriff (PDF)

The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine

Clinical cancer research, 2008-12, Vol.14 (24), p.8102-8111

2008

Volltextzugriff (PDF)

DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies

Communications biology, 2022-07, Vol.5 (1), p.741-741, Article 741

2022

Volltextzugriff (PDF)

T-cells in CLL: Victims or villains?

Leukemia research, 2009-06, Vol.33 (6), p.752-752

Pepper, Chris J

2009

Volltextzugriff (PDF)

Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3′-Deoxyadenosine, as a Potential Anticancer Agent

Journal of medicinal chemistry, 2022-12, Vol.65 (23), p.15789-15804

2022

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(262)
Mit Volltextzugriff
(264)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(140)
Humans
(129)
Hematology
(59)
Male
(48)
Oncology
(46)
Biological And Medical Sciences
(45)
Female
(44)
Medical Sciences
(42)
Middle Aged
(41)
Aged
(35)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(34)
Prognosis
(32)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(29)
Hematologic And Hematopoietic Diseases
(28)
Apoptosis
(27)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(27)
Adult
(25)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(22)
Antineoplastic Agents - Pharmacology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia

NF-kB and the CLL microenvironment

Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial)

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells

Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

Targeting CDK9 for treatment of colorectal cancer

Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma

Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia

The role of Bcl-2 family proteins in chronic lymphocytic leukaemia

Developing a post-myocardial infarction medicines optimisation clinic: core competencies for upskilling pharmacists and initial patient feedback

The HSP90 inhibitor NVP‐AUY922‐AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells

Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts

Computational modeling of DLBCL predicts response to BH3-mimetics

Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia

Is venetoclax a new wonder drug in CLL?

UK Expert Consensus Statement for the Optimal Use and Clinical Utility of Leadless Pacing Systems on Behalf of the British Heart Rhythm Society

A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL

The Novel Nuclear Factor-κB Inhibitor LC-1 Is Equipotent in Poor Prognostic Subsets of Chronic Lymphocytic Leukemia and Shows Strong Synergy with Fludarabine

DNA sequence-selective G-A cross-linking ADC payloads for use in solid tumour therapies

T-cells in CLL: Victims or villains?

Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3′-Deoxyadenosine, as a Potential Anticancer Agent

Suchergebnisse filtern